{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:54:51Z","timestamp":1763754891037,"version":"3.45.0"},"reference-count":36,"publisher":"Oncology Nursing Society (ONS)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2021,10,1]]},"DOI":"10.1188\/21.cjon.555-562","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T08:54:53Z","timestamp":1631868893000},"page":"555-562","source":"Crossref","is-referenced-by-count":1,"title":["Non-Hodgkin Lymphoma: Examining Mycosis Fungoides and S\u00e9zary Syndrome in the Context of Oncology Nursing"],"prefix":"10.1188","volume":"25","author":[{"given":"Karla","family":"Ow","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeannine","family":"Brant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"1","unstructured":"Acrotech Biopharma. (2020). Folotyn\u00ae (pralatrexate injection) [Package insert]. http:\/\/www.folotyn.com\/wp-content\/uploads\/2019\/11\/Folotyn-PI-09-2020-REF..."},{"key":"2","doi-asserted-by":"crossref","unstructured":"Alpdogan, O., Kartan, S., Johnson, W., Sokol, K., & Porcu, P. (2019). Systemic therapy of cutaneous T-cell lymphoma (CTCL). Chinese Clinical Oncology, 8(1), 20. https:\/\/doi.org\/10.21037\/cco.2019.01.02","DOI":"10.21037\/cco.2019.01.02"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Atkin, L. (2014). Understanding methods of wound debridement. British Journal of Nursing, 23(12, Suppl.), S10\u2013S15. https:\/\/doi.org\/10.12968\/bjon.2014.23.sup12.S10","DOI":"10.12968\/bjon.2014.23.sup12.S10"},{"key":"4","doi-asserted-by":"crossref","unstructured":"Berg, S., Villasenor-Park, J., Haun, P., & Kim, E.J. (2017). Multidisciplinary management of mycosis fungoides\/S\u00e9zary syndrome. Current Hematologic Malignancy Reports, 12(3), 234\u2013243. https:\/\/doi.org\/10.1007\/s11899-017-0387-9","DOI":"10.1007\/s11899-017-0387-9"},{"key":"5","doi-asserted-by":"crossref","unstructured":"Bhabha, F.K., McCormack, C., Wells, J., Campbell, B.A., Newland, K., Lade, S., . . . Prince, H.M. (2021). Mycosis fungoides and S\u00e9zary syndrome: Australian clinical practice statement. Australasian Journal of Dermatology, 62(1), e8\u2013e18. https:\/\/doi.org\/10.1111\/ajd.13467","DOI":"10.1111\/ajd.13467"},{"key":"6","unstructured":"Blecher, C.S., Ireland, A.M., & Watson, J.L. (2016). Standards of oncology education: Patient\/significant other and public (4th ed.). Oncology Nursing Society."},{"key":"7","unstructured":"Brown, C.G. (2015). Mucositis. In C.G. Brown (Ed.), A guide to oncology symptom management (2nd ed., pp. 469\u2013482). Oncology Nursing Society."},{"key":"8","unstructured":"Dest, V.M. (2016). Neurologic, ocular, and dermatologic toxicities. In B.H. Gobel, S. Triest-Robertson, & W.H. Vogel (Eds.), Advanced oncology nursing certification review and resource manual (2nd ed., pp. 577\u2013641). Oncology Nursing Society."},{"key":"9","doi-asserted-by":"crossref","unstructured":"Duffy, R., Jennings, T., & Sahu, J. (2019). Gentle skin care guidelines for patients with mycosis fungoides. Chinese Clinical Oncology, 8(1), 14. https:\/\/doi.org\/10.21037\/cco.2018.10.04","DOI":"10.21037\/cco.2018.10.04"},{"key":"10","doi-asserted-by":"crossref","unstructured":"Duvic, M. (2013). Cutaneous T-cell lymphomas: Mycosis fungoides and S\u00e9zary syndrome. In A. Younes & B. Coiffier (Eds.), Lymphoma: Diagnosis and treatment (pp. 287\u2013329). Humana Press.","DOI":"10.1007\/978-1-62703-408-1_19"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Jawed, S.I., Myskowski, P.L., Horwitz, S., Moskowitz, A., & Querfeld, C. (2014). Primary cutaneous T-cell lymphoma (mycosis fungoides and S\u00e9zary syndrome): Part II. Prognosis, management, and future directions. Journal of the American Academy of Dermatology, 70(2), 223.e1\u2013223.e17. https:\/\/doi.org\/10.1016\/j.jaad.2013.08.033","DOI":"10.1016\/j.jaad.2013.08.033"},{"key":"12","doi-asserted-by":"crossref","unstructured":"Johnson, W.T., Mukherji, R., Kartan, S., Nikbakht, N., Porcu, P., & Alpdogan, O. (2019). Allogeneic hematopoietic stem cell transplantation in advanced stage mycosis fungoides and S\u00e9zary syndrome: A concise review. Chinese Clinical Oncology, 8(1), 12. https:\/\/doi.org\/10.21037\/cco.2018.10.03","DOI":"10.21037\/cco.2018.10.03"},{"key":"13","doi-asserted-by":"crossref","unstructured":"Kempf, W., Zimmermann, A.K., & Mitteldorf, C. (2019). Cutaneous lymphomas\u2014An update 2019. Hematological Oncology, 37(Suppl. 1), 43\u201347. https:\/\/doi.org\/10.1002\/hon.2584","DOI":"10.1002\/hon.2584"},{"key":"14","doi-asserted-by":"crossref","unstructured":"Larocca, C., & Kupper, T. (2019). Mycosis fungoides and S\u00e9zary syndrome: An update. Hematology\/Oncology Clinics of North America, 33(1), 103\u2013120. https:\/\/doi.org\/10.1016\/j.hoc.2018.09.001","DOI":"10.1016\/j.hoc.2018.09.001"},{"key":"15","doi-asserted-by":"crossref","unstructured":"Larocca, C.A., & LeBoeuf, N.R. (2019). Overview of cutaneous T-cell lymphomas. Hematology\/Oncology Clinics of North America, 33(4), 669\u2013686. https:\/\/doi.org\/10.1016\/j.hoc.2019.04.004","DOI":"10.1016\/j.hoc.2019.04.004"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Lewis, D.J., Holder, B.B., & Duvic, M. (2018). The \u201cDuvic regimen\u201d for erythrodermic flares secondary to staphylococcus aureus in mycosis fungoides and S\u00e9zary syndrome. International Journal of Dermatology, 57(1), 123\u2013124. https:\/\/doi.org\/10.1111\/ijd.13832","DOI":"10.1111\/ijd.13832"},{"key":"17","doi-asserted-by":"crossref","unstructured":"Lewis, D.J., Kim, E.J., & Duvic, M. (2017). Recent advances in systemic targeted therapy for cutaneous T-cell lymphoma. Expert Opinion on Pharmacotherapy, 18(14), 1535\u20131536. https:\/\/doi.org\/10.1080\/14656566.2017.1367594","DOI":"10.1080\/14656566.2017.1367594"},{"key":"18","doi-asserted-by":"crossref","unstructured":"Lucas, A. S., & Ciccolini, K. (2016). Nursing best practice referral algorithm for the early detection of mycosis fungoides. Journal of the Dermatology Nurses\u2019 Association, 8(2), 109\u2013120. https:\/\/doi.org\/10.1097\/JDN.0000000000000205","DOI":"10.1097\/JDN.0000000000000205"},{"key":"19","doi-asserted-by":"crossref","unstructured":"Martinez, X.U., Di Raimondo, C., Abdulla, F.R., Zain, J., Rosen, S.T., & Querfeld, C. (2019). Leukaemic variants of cutaneous T-cell lymphoma: Erythrodermic mycosis fungoides and S\u00e9zary syndrome. Best Practice and Research Clinical Haematology, 32(3), 239\u2013252. https:\/\/doi.org\/10.1016\/j.beha.2019.06.004","DOI":"10.1016\/j.beha.2019.06.004"},{"key":"20","doi-asserted-by":"crossref","unstructured":"Mehta-Shah, N., Horwitz, S.M., Ansell, S., Ai, W.Z., Barnes, J., Barta, S.K., . . . Kim, Y.H. (2020). NCCN Guidelines Insights: Primary cutaneous lymphomas, version 2.2020. Journal of the National Comprehensive Cancer Network, 18(5), 522\u2013536. https:\/\/doi.org\/10.6004\/jnccn.2020.0022","DOI":"10.6004\/jnccn.2020.0022"},{"key":"21","doi-asserted-by":"crossref","unstructured":"Mercadante, S., Aielli, F., Adile, C., Ferrera, P., Valle, A., Fusco, F., . . . Porzio, G. (2015). Prevalence of oral mucositis, dry mouth, and dysphagia in advanced cancer patients. Supportive Care in Cancer, 23(11), 3249\u20133255. https:\/\/doi.org\/10.1007\/s00520-015-2720-y","DOI":"10.1007\/s00520-015-2720-y"},{"key":"22","unstructured":"Mooney, K. (2019). Cutaneous toxicities and alopecia. In M.M. Olsen, K.B. Levebre, & K.J. Brassil (Eds.), Chemotherapy and immunotherapy guidelines and recommendations for practice (pp. 501\u2013523). Oncology Nursing Society."},{"key":"23","unstructured":"National Comprehensive Cancer Network. (2021a). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Hematopoitic growth factors [v.4.2021]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/growthfactors.pdf"},{"key":"24","unstructured":"National Comprehensive Cancer Network. (2021b). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae): Primary cutaneous lymphoma [v.2.2021]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/primary_cutaneous.pdf"},{"key":"25","doi-asserted-by":"crossref","unstructured":"Olsen, E.A. (2015). Evaluation, diagnosis, and staging of cutaneous lymphoma. Dermatologic Clinic, 33(4), 643\u2013654. https:\/\/doi.org\/10.1016\/j.det.2015.06.001","DOI":"10.1016\/j.det.2015.06.001"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Photiou, L., van der Weyden, C., McCormack, C., & Miles Prince, H. (2018). Systemic treatment options for advanced-stage mycosis fungoides and S\u00e9zary syndrome. Current Oncology Reports, 20(4), 32. https:\/\/doi.org\/10.1007\/s11912-018-0678-x","DOI":"10.1007\/s11912-018-0678-x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Pulitzer, M. (2017). Cutaneous T-cell lymphoma. Clinics in laboratory medicine, 37(3), 527\u2013546. https:\/\/doi.org\/10.1016\/j.cll.2017.06.006","DOI":"10.1016\/j.cll.2017.06.006"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Scarisbrick, J.J., Prince, H.M., Vermeer, M.H., Quaglino, P., Horwitz, S., Porcu, P., . . . Kim, Y.H. (2015). Cutaneous Lymphoma International Consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: Effect of specific prognostic markers on survival and development of a prognostic model. Journal of Clinical Oncology, 33(32), 3766\u20133773. https:\/\/doi.org\/10.1200\/jco.2015.61.7142","DOI":"10.1200\/JCO.2015.61.7142"},{"key":"29","unstructured":"Shelton, B. (2016). Myelosuppresion and second malignacies. In B.H. Gobel, S. Triest-Robertson, & W.H. Vogel (Eds.), Advanced oncology nursing certification review and resource manual (2nd ed., pp. 451\u2013490). Oncology Nursing Society."},{"key":"30","doi-asserted-by":"crossref","unstructured":"Song, J., Xian, D., Yang, L., Xiong, X., Lai, R., & Zhong, J. (2018). Pruritus: Progress toward pathogenesis and treatment. BioMed Research International, 2018, 9625936. https:\/\/doi.org\/10.1155\/2018\/9625936","DOI":"10.1155\/2018\/9625936"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Trautinger, F., Eder, J., Assaf, C., Bagot, M., Cozzio, A., Dummer, R., . . . Knobler, R. (2017). European Organisation for Research and Treatment of Cancer consensus recommendations for the treatment of mycosis fungoides\/S\u00e9zary syndrome\u2014Update 2017. European Journal of Cancer, 77, 57\u201374. https:\/\/doi.org\/10.1016\/j.ejca.2017.02.027","DOI":"10.1016\/j.ejca.2017.02.027"},{"key":"32","doi-asserted-by":"crossref","unstructured":"Virmani, P., Hwang, S.H., Hastings, J.G., Haverkos, B.M., Kohnken, B., Gru, A.A., . . . Porcu, P. (2017). Systemic therapy for cutaneous T-cell lymphoma: Who, when, what, and why? Expert Review of Hematology, 10(2), 111\u2013121. https:\/\/doi.org\/10.1080\/17474086.2017.1270201","DOI":"10.1080\/17474086.2017.1270201"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Virmani, P., Zain, J., Rosen, S.T., Myskowski, P.L., & Querfeld, C. (2015). Hematopoietic stem cell transplant for mycosis fungoides and S\u00e9zary syndrome. Dermatologic Clinics, 33(4), 807\u2013818. https:\/\/doi.org\/10.1016\/j.det.2015.05.014","DOI":"10.1016\/j.det.2015.05.014"},{"key":"34","doi-asserted-by":"crossref","unstructured":"Wilcox, R.A. (2017). Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management. American Journal of Hematology, 92(10), 1085\u20131102. https:\/\/doi.org\/10.1002\/ajh.24876","DOI":"10.1002\/ajh.24876"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Willemze, R., Cerroni, L., Kempf, W., Berti, E., Facchetti, F., Swerdlow, S.H., & Jaffe, E.S. (2019). The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood, 133(16), 1703\u20131714. https:\/\/doi.org\/10.1182\/blood-2018-11-881268","DOI":"10.1182\/blood-2018-11-881268"},{"key":"36","doi-asserted-by":"crossref","unstructured":"Wound, Ostomy, and Continence Nurses Society Task Force. (2018). Wound, ostomy, and continence nursing: Scope and standards of WOC practice, 2nd edition: An executive summary. Journal of Wound, Ostomy, and Continence Nursing, 45(4), 369\u2013387. https:\/\/doi.org\/10.1097\/WON.0000000000000438","DOI":"10.1097\/WON.0000000000000438"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/25\/5\/non-hodgkin-lymphoma-examining-mycosis-fungoides-and-s-zary-syndrome-context-oncology","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:49:30Z","timestamp":1763754570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/25\/5\/non-hodgkin-lymphoma-examining-mycosis-fungoides-and-sezary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":36,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10,1]]}},"URL":"https:\/\/doi.org\/10.1188\/21.cjon.555-562","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"type":"print","value":"1092-1095"},{"type":"electronic","value":"1538-067X"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}